Rodriguez V M, Catalina M L, García-Noblejas J A, Cuesta P
Department of Psychiatry, Hospital Gregorio Mararion, Madrid, Spain.
Psychiatry Res. 1998 Jan 16;77(1):21-8. doi: 10.1016/s0165-1781(97)00129-7.
Relationships between symptom profile and clozapine response were studied. Symptom scores on the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms were subjected to principal component analysis (PCA) in a group of 66 treatment-resistant schizophrenic patients, 49 of whom were treated with clozapine. Factor scores were compared among responders, non-responders and partial responders. The PCA yielded a four-factor solution, with positive symptoms, negative symptoms, cognitive disorganization and behavioral disorganization components. Cognitive and behavioral disorganization syndrome scores showed significant differences across groups. Cognitive disorganization was higher in non-responders, while behavioral disorganization was higher in partial responders. The results support the possibility of using clinical profiles to predict therapeutic response to clozapine.
研究了症状特征与氯氮平反应之间的关系。在一组66例难治性精神分裂症患者中,对阳性症状评定量表和阴性症状评定量表上的症状评分进行了主成分分析(PCA),其中49例患者接受了氯氮平治疗。比较了有效者、无效者和部分有效者的因子得分。主成分分析得出了一个四因子解决方案,包括阳性症状、阴性症状、认知紊乱和行为紊乱成分。认知和行为紊乱综合征评分在各组之间存在显著差异。无效者的认知紊乱较高,而部分有效者的行为紊乱较高。结果支持利用临床特征预测氯氮平治疗反应的可能性。